Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2Rγ(Null) Mice Mimics Human Myeloma and Serves as a Valuable Tool for the Development of Anticancer Strategies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intratibial Injection of Human Multiple Myeloma Cells in NOD/SCID IL-2Rγ(Null) Mice Mimics Human Myeloma and Serves as a Valuable Tool for the Development of Anticancer Strategies
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 11, Pages e79939
Publisher
Public Library of Science (PLoS)
Online
2013-11-07
DOI
10.1371/journal.pone.0079939
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potentin vitroandin vivoactivity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization
- (2013) Josefina Udi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Preclinical models of multiple myeloma: a critical appraisal
- (2013) Julia Schüler et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Characterization of a Novel Mouse Model of Multiple Myeloma and Its Use in Preclinical Therapeutic Assessment
- (2013) Rosemary A. Fryer et al. PLoS One
- Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
- (2012) A. Chaidos et al. BLOOD
- Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma
- (2012) R. W. J. Groen et al. BLOOD
- Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
- (2012) T. K. Garg et al. HAEMATOLOGICA
- Optical Imaging of Disseminated Leukemia Models in Mice with Near-Infrared Probe Conjugated to a Monoclonal Antibody
- (2012) Sabrina Pesnel et al. PLoS One
- Dual-Wavelength Imaging of Tumor Progression by Activatable and Targeting Near-Infrared Fluorescent Probes in a Bioluminescent Breast Cancer Model
- (2012) Bang-Wen Xie et al. PLoS One
- Non-Invasive Imaging Provides Spatiotemporal Information on Disease Progression and Response to Therapy in a Murine Model of Multiple Myeloma
- (2012) Simone S. Riedel et al. PLoS One
- Diversity of Human Leukemia Xenograft Mouse Models: Implications for Disease Biology
- (2011) L. H. Meyer et al. CANCER RESEARCH
- New criteria for analyzing the statistical relationships between biological parameters and therapeutic responses of xenografted tumor models
- (2011) Jacques Medioni et al. Contemporary Clinical Trials
- Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing
- (2011) Marianne Frøyland et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
- (2011) T Calimeri et al. LEUKEMIA
- Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy
- (2011) Martina Kleber et al. LEUKEMIA & LYMPHOMA
- Sensitive Dual Color In Vivo Bioluminescence Imaging Using a New Red Codon Optimized Firefly Luciferase and a Green Click Beetle Luciferase
- (2011) Laura Mezzanotte et al. PLoS One
- Comparison of human cord blood engraftment between immunocompromised mouse strains
- (2010) S. P. McDermott et al. BLOOD
- European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma
- (2010) Monika Engelhardt et al. LEUKEMIA & LYMPHOMA
- Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms
- (2010) Sarah K. Brennan et al. PLoS One
- A robust xenotransplantation model for acute myeloid leukemia
- (2009) P V Sanchez et al. LEUKEMIA
- Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma
- (2009) F. van Rhee et al. MOLECULAR CANCER THERAPEUTICS
- Cancer stem cells in multiple myeloma
- (2008) Nilanjan Ghosh et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started